...
首页> 外文期刊>Tropical Journal of Pharmaceutical Research >Computational and pharmacological evaluation of stevioside derivatives for antinociceptive and anti-inflammatory potential
【24h】

Computational and pharmacological evaluation of stevioside derivatives for antinociceptive and anti-inflammatory potential

机译:抗炎症性抗炎潜力的甜菊糖衍生物的计算与药理评价

获取原文
           

摘要

Purpose: To carry out computational and pharmacological evaluation of two stevioside derivatives in order to develop more effective candidates for analgesia and inflammation. Methods: Primarily, compounds were docked against targets of nociception and inflammation such as cyclooxygenase-1, cyclooxygenase-2, 5-lypooxygenase 12-lypooxygenase, 15-lypooxygenase, prostaglandin synthase, leukotrienes C4 synthase, mu, kappa, and delta receptors to obtain their possible binding modes. Test compounds were then screened in animal model of nociception and inflammation. Results: The results of docking show that IO possesses good affinity when compared to ID. IO showed two hydrogen bonds against COX-1 and COX-2. IO also demonstrated good binding against 5-LOX, 12-LOX and 15-LOX, exhibited four, one and two hydrogen bonds respectively. Against PG synthase and LTC4, both IO and ID produced moderate binding. IO also showed significant binding against opoid receptors (p 0.05). IO and ID significantly decrease the number of writhes to 21.20 ± 2.1 and 27.0 ± 2.12 at 10 mg/kg in acetic acid mediated pain test respectively. In hot plate method, IO and ID increase the latency period of mice to 14.14 ± 0.40 and 10.50 ± 0.34 s, respectively. IO and ID significantly reduced the paw edema to 1.69 ± 0.14 and 1.94 ± 0.14 mL, respectively, in acute inflammation (p 0.05). In chronic inflammatory model, IO and ID decreased paw volume to 3.26 ± 0.38 and 4.20 ± 0.38 mL, respectively. Conclusion: The results show that IO is a promising candidate for further development as analgesic and anti-inflammatory agents. However, their pharmacokinetic and pharmacodynamic profiles need to be investigated.
机译:目的:进行两种甜菊糖衍生物的计算和药理评估,以便为镇痛和炎症进行更有效的候选者。方法:主要,将化合物对接对烟蛋白和炎症的靶标如环氧基酶-1,环氧氢止酶-2,5-氯氧基酶12-氯氰基酶,15-氯砜酶,前列腺素合酶,白三烯C4合酶,MU,Kappa和Delta受体获得他们可能的绑定模式。然后将测试化合物筛选在伤害和炎症的动物模型中。结果:与ID相比,对接结果表明IO具有良好的亲和力。 IO展示了两种氢键对COX-1和COX-2。 IO还表现出对5-LOX,12-LOX和15-LOX的良好结合,分别显示出四个,一个和两个氢键。针对PG合成酶和LTC4,IO和ID都产生了适度的结合。 IO还表现出对Opoid受体的显着结合(P <0.05)。 IO和ID分别在乙酸介导的疼痛试验中显着降低21.20±2.1和27.0±2.12.12.0±2.12.12.0±2.12。在热板方法中,IO和ID分别将小鼠的潜伏期增加到14.14±0.40和10.50±0.34秒。 IO和ID显着将PAW水肿显着降低至1.69±0.14和1.94±0.14ml,分别在急性炎症中(P <0.05)。在慢性炎症模型中,IO和ID分别降低爪体积至3.26±0.38和4.20±0.38ml。结论:结果表明,IO是进一步开发作为镇痛和抗炎剂的有希望的候选者。然而,需要研究它们的药代动力学和药物动力学谱。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号